Anthem Biosciences Limited (NSE:ANTHEM)
India · Delayed Price · Currency is INR 810.00
+25.60 (3.26%)
Jul 31, 2026, 3:30 PM IST
Anthem Biosciences Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Anthem Biosciences stock has a consensus rating of "Strong Buy" and an average price target of ₹884.43. The average 1-year stock price forecast is 9.19% higher than the current stock price, while the lowest is ₹830.00 (+2.47%) and the highest is ₹941.00 (+16.17%).
Price Target: ₹884.43 (+9.19%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Anthem Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains ₹900.00 | Buy | Maintains | ₹900.00 | +11.11% | Jul 23, 2026 |
Unknown Analyst Prabhudas Lilladher No rating | Prabhudas Lilladher | Buy Initiates ₹755.00 | Buy | Initiates | ₹755.00 | -6.79% | Mar 30, 2026 |
Financial Forecast
Revenue This Year
25.64B
from 21.29B
Increased by 20.43%
Revenue Next Year
30.82B
from 25.64B
Increased by 20.18%
EPS This Year
12.83
from 10.74
Increased by 19.46%
EPS Next Year
15.27
from 12.83
Increased by 19.02%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.